XML 36 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (8,330,761) $ (12,253,707)
Adjustments to reconcile net loss to net cash (used in) operating activities:    
Depreciation and impairment of lease merchandise 31,453,246 22,734,553
Other depreciation and amortization 2,090,581 1,566,507
Compensation expense related to issuance of stock options and warrants 113,952 136,308
Provision for uncollectible accounts 19,135,207 13,281,242
Changes in operating assets and liabilities:    
Accounts receivable (21,212,888) (14,710,870)
Prepaid expenses and other 32,296 (124,707)
Lease merchandise (34,298,108) (30,100,878)
Security deposits (10,206) (1,493)
Accounts payable 3,784,397 2,133,818
Accrued payroll and related taxes 108,013 44,814
Accrued expenses 535,437 (78,016)
Net cash (used in) operating activities (6,598,834) (17,372,429)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment, including capitalized software costs (2,021,538) (1,855,088)
Net cash (used in) investing activities (2,021,538) (1,855,088)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds of loans from shareholder 1,000,000
Repayment of loans from shareholder (1,000,000)
Proceeds from loan payable under credit agreement 10,450,000 4,941,359
Repayment of loan payable under credit agreement (2,288,208) (4,172,714)
Proceeds from exercise of stock options 15,000 42,500
Proceeds from sale of Series 2 Convertible Preferred Stock, net of related costs of $1,519,339 in 2016 20,432,661
Net cash provided by financing operations 8,176,792 21,243,806
(DECREASE)/ INCREASE IN CASH (443,580) 2,016,289
CASH, beginning of year 5,412,495 3,396,206
CASH, end of year 4,968,915 5,412,495
Supplemental cash flow information:    
Interest paid 1,649,795 1,459,756
Non-cash financing activities:    
Conversion of preferred stock to common stock 18,300 425,660
Warrants issued to placement agent in conjunction with sale of Series 2 Preferred Stock $ 150,451